Ginkgo Bioworks Holdings Inc (NYSE:DNA) Given Consensus Rating of Buy by Brokerages

Shares of Ginkgo Bioworks Holdings Inc (NYSE:DNA – Get Rating) have earned a consensus recommendation of “Buy” from the nine research firms that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price […]

Related Keywords

United States ,America , ,Eagle Acquisition Corp ,Ginkgo Bioworks Holdings Inc ,Investment Group ,Zacks Investment Research ,Investment Management ,Baillie Gifford Co ,Ginkgo Bioworks Company Profile Get Rating ,Goldman Sachs Group ,Get Rating ,Ginkgo Bioworks ,Investment Research ,Global Investors ,Bioworks Company Profile ,Soaring Eagle Acquisition Corp ,Nyse Dna ,Dna ,Medical ,Ratings ,Consensus ,